Quoted from http://www.businessweek.com/news/2010-12-03/pfizer-properly-warned-about-prempro-risks-jury-finds.html
Pfizer Properly Warned About Prempro Risks, Jury Finds
December 03, 2010, 12:05 PM EST
By Jef Feeley
(Updates with company comment in third paragraph.)
Dec. 3 (Bloomberg) -- Pfizer Inc.’s Wyeth unit properly warned a Virginia woman’s doctors about the risks of its Prempro menopause drug, a jury ruled today in rejecting her claim for damages.
Jurors in federal court in Alexandria, Virginia, deliberated about four hours over two days before finding that Georgia Torkie-Tork couldn’t show that Wyeth officials downplayed the breast-cancer risks associated with Prempro, a hormone-replacement drug. The decision was Wyeth’s fourth straight victory in a Prempro suit weighed by a jury.
“We believe the verdict in this case affirms that Wyeth communicated the risks and benefits of Prempro,” Chris Loder, a spokesman for New York-based Pfizer, said in an e-mailed statement.
More than 6 million women took Prempro and related menopause drugs to treat symptoms such as hot flashes and mood swings before a 2002 study highlighted their links to cancer. Wyeth’s sales of the medicines, which are still on the market, topped $2 billion before the release of the Women’s Health Initiative, a National Institutes of Health-sponsored study.
[Article continues at original source]